SIRT1 and diabetic kidney disease: PMSCs can significantly improve kidney injury and reduce podocyte damage in DKD rats by regulating the SIRT1-PGC-1α-TFAM pathway and enhancing PINK1/Parkin-mediated podocyte mitophagy [57].